Holdings of Velan Capital Investment Management LP
43 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 78 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 93.6 %
- FR 5.7 %
- AU 0.7 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 41 | 139.9M $ | 93.59 % |
| 2 | FR | 1 | 8.6M $ | 5.74 % |
| 3 | AU | 1 | 1M $ | 0.67 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Praxis Precision Medicines Inc | 100,781 | 32.5M $ | |
| 2 | Protara Therapeutics Inc | 2,834,652 | 14.8M $ | |
| 3 | Sutro Biopharma Inc | 512,160 | 12.8M $ | |
| 4 | Evommune Inc | 446,255 | 10.3M $ | |
| 5 | MapLight Therapeutics Inc | 492,893 | 10M $ | |
| 6 | Tenax Therapeutics Inc | 583,333 | 9.3M $ | |
| 7 | Abivax SA | 77,000 | 8.6M $ | |
| 8 | Heron Therapeutics Inc | 8,753,290 | 7M $ | |
| 9 | Immix Biopharma Inc | 740,000 | 6.7M $ | |
| 10 | Esperion Therapeutics Inc | 1,720,000 | 4.7M $ | |
| 11 | Anteris Technologies Global Corp | 700,000 | 3.9M $ | |
| 12 | InspireMD, Inc. | 2,099,652 | 3.4M $ | |
| 13 | Xencor Inc | 250,000 | 3M $ | |
| 14 | AVALO THERAPEUTICS INC | 185,122 | 2.8M $ | |
| 15 | CytomX Therapeutics Inc | 540,000 | 2.5M $ | |
| 16 | Verrica Pharmaceuticals Inc | 471,559 | 2.5M $ | |
| 17 | JASPER THERAPEUTICS INC | 2,668,395 | 2.3M $ | |
| 18 | Rezolute Inc | 750,000 | 2.3M $ | |
| 19 | Lyell Immunopharma Inc | 102,000 | 2M $ | |
| 20 | Viridian Therapeutics Inc | 91,123 | 1.8M $ | |
| 21 | Rocket Pharmaceuticals Inc | 294,643 | 1.1M $ | |
| 22 | KAZIA THERAPEUTICS LTD | 135,315 | 1M $ | |
| 23 | Arrowhead Pharmaceuticals Inc | 6,500 | 407.6K $ | |
| 24 | Protagonist Therapeutics Inc | 3,700 | 390K $ | |
| 25 | Ovid therapeutics Inc | 160,000 | 355.2K $ | |
| 26 | Mineralys Therapeutics Inc | 11,000 | 298K $ | |
| 27 | Context Therapeutics Inc | 100,000 | 262K $ | |
| 28 | Nurix Therapeutics Inc | 16,000 | 248K $ | |
| 29 | Corbus Pharmaceuticals Holdings Inc | 26,000 | 244.1K $ | |
| 30 | Syndax Pharmaceuticals Inc | 10,000 | 233.6K $ | |
| 31 | Precision BioSciences Inc | 40,000 | 220K $ | |
| 32 | Immunome Inc | 10,000 | 218.7K $ | |
| 33 | Design Therapeutics Inc | 20,000 | 212.8K $ | |
| 34 | Artiva Biotherapeutics Inc | 25,000 | 161K $ | |
| 35 | Neumora Therapeutics Inc | 80,000 | 156K $ | |
| 36 | Replimune Group Inc | 20,000 | 153K $ | |
| 37 | Larimar Therapeutics Inc | 33,000 | 148.5K $ | |
| 38 | Xilio Therapeutics Inc | 14,285 | 120.1K $ | |
| 39 | KALARIS THERAPEUTICS INC | 18,000 | 103.9K $ | |
| 40 | PMV Pharmaceuticals Inc | 73,000 | 90.5K $ | |
| 41 | MacroGenics Inc | 30,000 | 86.7K $ | |
| 42 | Karyopharm Therapeutics Inc | 15,000 | 83.6K $ | |
| 43 | Gossamer Bio Inc | 70,000 | 23K $ | |